ACCESS THYROGLOBULIN ANTIBODY II REAGENT A32898

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a 01,05,06 report with the FDA on 2015-05-12 for ACCESS THYROGLOBULIN ANTIBODY II REAGENT A32898 manufactured by Beckman Coulter.

Event Text Entries

[21180185] The customer reported obtaining a normal thyroglobulin antibody (access thyroglobulin antibody ii) result for one (1) patient on the unicel dxi 800 access immunoassay system (serial number (b)(4)) that was discordant to two (2) other methodologies. The customer analyzed the patient's sample on an alternate methodology (roche) and obtained a discordant, higher result above the assay's normal reference range. The customer also analyzed the patient's sample on a second methodology (siemens) and again obtained a discordant, higher result above the assay's normal reference range. The access thyroglobulin antibody ii result was not reported outside the laboratory. There was no report of patient injury or change in patient treatment associated with this event. Assay calibration was performing within published specifications. Qc (quality control) and system check data was not supplied by the customer. The customer did not supply information regarding sample collection such as tube type. The patient's sample was centrifuged for ten (10) minutes at 3,000 rpm (revolutions per minute) at room temperature. There was no report of sample integrity issues reported by the customer.
Patient Sequence No: 1, Text Type: D, B5


[21220497] The full name of the establishment is the (b)(6). Service was not dispatched. Calibration passed on april 3, 2015 with access thyroglobulin antibody ii reagent lot 431463 and calibrator lot 435844. There is no evidence of pre-analytical sample handling issue and no indication that the access thyroglobulin antibody ii reagent was returned for evaluation. In conclusion, the cause of the event cannot be determined with the available information.
Patient Sequence No: 1, Text Type: N, H10


MAUDE Entry Details

Report Number2122870-2015-00284
MDR Report Key4766219
Report Source01,05,06
Date Received2015-05-12
Date of Report2015-04-21
Date of Event2015-04-21
Date Mfgr Received2015-04-21
Device Manufacturer Date2014-10-01
Date Added to Maude2015-06-09
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Reporter OccupationOTHER HEALTH CARE PROFESSIONAL
Health Professional3
Initial Report to FDA3
Report to FDA0
Event Location0
Manufacturer ContactMR. JEFFREY KOLL
Manufacturer Street1000 LAKE HAZELTINE DRIVE
Manufacturer CityCHASKA MN 55318
Manufacturer CountryUS
Manufacturer Postal55318
Manufacturer Phone9523681361
Manufacturer G1BECKMAN COULTER
Manufacturer Street1000 LAKE HAZELTINE DRIVE
Manufacturer CityCHASKA MN 55318
Manufacturer CountryUS
Manufacturer Postal Code55318
Single Use3
Previous Use Code3
Removal Correction NumberNA
Event Type3
Type of Report3

Device Details

Brand NameACCESS THYROGLOBULIN ANTIBODY II REAGENT
Generic NameIMMUNOCHEMICAL, THYROGLOBULIN AUTOANTIBODY
Product CodeJNL
Date Received2015-05-12
Model NumberNA
Catalog NumberA32898
Lot Number431463
Device Expiration Date2015-09-30
OperatorHEALTH PROFESSIONAL
Device Eval'ed by MfgrN
Device Sequence No1
Device Event Key0
ManufacturerBECKMAN COULTER
Manufacturer Address1000 LAKE HAZELTINE DRIVE CHASKA MN 55318 US 55318


Patients

Patient NumberTreatmentOutcomeDate
10 2015-05-12

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.